These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35358491)

  • 1. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
    Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
    JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
    Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
    Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
    Forbes H; Morton CE; Bacon S; McDonald HI; Minassian C; Brown JP; Rentsch CT; Mathur R; Schultze A; DeVito NJ; MacKenna B; Hulme WJ; Croker R; Walker AJ; Williamson EJ; Bates C; Mehrkar A; Curtis HJ; Evans D; Wing K; Inglesby P; Drysdale H; Wong AYS; Cockburn J; McManus R; Parry J; Hester F; Harper S; Douglas IJ; Smeeth L; Evans SJW; Bhaskaran K; Eggo RM; Goldacre B; Tomlinson LA
    BMJ; 2021 Mar; 372():n628. PubMed ID: 33737413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease severity during SARS-COV-2 reinfection: a nationwide study.
    Mensah AA; Lacy J; Stowe J; Seghezzo G; Sachdeva R; Simmons R; Bukasa A; O'Boyle S; Andrews N; Ramsay M; Campbell H; Brown K
    J Infect; 2022 Apr; 84(4):542-550. PubMed ID: 35085659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study.
    Suljič A; Sočan M; Mrzel M; Lunar MM; Korva M; Štorman A; Prosenc K; Janežič S; Žohar-Čretnik T; Zupanič T; Poljak M; Avšič-Županc T
    Front Med (Lausanne); 2022; 9():962653. PubMed ID: 36275814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
    Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
    Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
    Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
    Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
    Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
    Nab L; Parker EPK; Andrews CD; Hulme WJ; Fisher L; Morley J; Mehrkar A; MacKenna B; Inglesby P; Morton CE; Bacon SCJ; Hickman G; Evans D; Ward T; Smith RM; Davy S; Dillingham I; Maude S; Butler-Cole BFC; O'Dwyer T; Stables CL; Bridges L; Bates C; Cockburn J; Parry J; Hester F; Harper S; Zheng B; Williamson EJ; Eggo RM; Evans SJW; Goldacre B; Tomlinson LA; Walker AJ;
    Lancet Public Health; 2023 May; 8(5):e364-e377. PubMed ID: 37120260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
    Kubale J; Balmaseda A; Frutos AM; Sanchez N; Plazaola M; Ojeda S; Saborio S; Lopez R; Barilla C; Vasquez G; Moreira H; Gajewski A; Campredon L; Maier HE; Chowdhury M; Cerpas C; Harris E; Kuan G; Gordon A
    JAMA Netw Open; 2022 Jun; 5(6):e2218794. PubMed ID: 35759261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 reinfections during the Delta and Omicron waves.
    Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 reinfections in Mexico City: implications for public health.
    de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
    Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Coyle P; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Tang P; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
    PLoS Med; 2021 Dec; 18(12):e1003879. PubMed ID: 34914711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
    Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.